Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial
- PMID: 38739291
- DOI: 10.1007/s00125-024-06167-8
Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial
Erratum for
-
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.Diabetologia. 2023 May;66(5):813-825. doi: 10.1007/s00125-023-05876-w. Epub 2023 Feb 6. Diabetologia. 2023. PMID: 36746803 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
